[Certain and disputed indications of immunosuppressive therapy in kidney diseases].
The effect of immunosuppressive agents in different glomerulopathies is reviewed and some guidelines for their use in clinical practice are proposed. The immunological aspects of pyelonephritis and interstitial nephritis are studied to evaluate future possibilities of either therapeutic immunosuppression or immunization in these diseases.
D005921:Glomerulonephritis / Q000628:therapy; D005923:Glomerulosclerosis, Focal Segmental / Q000628:therapy; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007674:Kidney Diseases / Q000628:therapy*; D009395:Nephritis, Interstitial / Q000628:therapy; D011704:Pyelonephritis / Q000628:therapy
D007166:Immunosuppressive Agents
Sichere und umstrittene Indikationen für die immunsuppressive Behandlung von Nierenkrankheiten.